UBS Group’s Nutanix NTNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$95K Sell
2,500
-2,500
-50% -$105K ﹤0.01% 7027
2025
Q4
$258K Buy
+5,000
New +$306K ﹤0.01% 6446
2025
Q3
Sell
-1,200
Closed -$91.7K 10737
2025
Q2
$91.7K Buy
+1,200
New +$86.4K ﹤0.01% 7312
2024
Q1
Sell
-75,000
Closed -$3.58M 9802
2023
Q4
$3.58M Buy
75,000
+65,700
+706% +$2.66M ﹤0.01% 3137
2023
Q3
$324K Buy
+9,300
New +$292K ﹤0.01% 4992
2023
Q2
Sell
-125,000
Closed -$3.25M 9411
2023
Q1
$3.25M Buy
125,000
+65,000
+108% +$1.76M ﹤0.01% 2923
2022
Q4
$1.56M Buy
+60,000
New +$1.64M ﹤0.01% 3632
2018
Q3
Sell
-17,700
Closed -$913K 8163
2018
Q2
$913K Buy
+17,700
New +$973K ﹤0.01% 3847

Other funds holding NTNX

UBS Group's NTNX Position: Q1 2026 in Review

UBS Group reduced its Nutanix (NTNX) stake by 5.4% in Q1 2026, selling an estimated $3.86M and leaving 1,612,340 shares worth $61.3M. The position accounts for 0.01% of the portfolio, ranked #1437.

UBS Group first reported a position in NTNX in Q3 2016 and has held it in 39 quarters since. The position peaked at $110M in Q3 2025. 534 funds tracked by Wall St. Rank hold NTNX as of Q1 2026.

  • UBS Group held 1,612,340 shares of Nutanix worth $61.3M as of Q1 2026.
  • UBS Group sold 91,624 Nutanix shares in Q1 2026, an estimated $3.86M.
  • Nutanix made up 0.01% of UBS Group's portfolio in Q1 2026, its #1437 holding.
  • UBS Group first reported a position in Nutanix in Q3 2016 and has held it in 39 quarters since.
  • UBS Group's Nutanix position peaked at $110M in Q3 2025.
  • 534 funds tracked by Wall St. Rank held Nutanix as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.